002422 科伦药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.19913.93013.87411.5268.061
总资产报酬率 ROA (%)3.1027.9596.9525.1883.471
投入资产回报率 ROIC (%)4.25910.5118.9576.6214.357

边际利润分析
销售毛利率 (%)47.88751.69352.43052.51655.664
营业利润率 (%)13.40620.29317.03311.5307.639
息税前利润/营业总收入 (%)12.76919.95017.77913.3829.743
净利润/营业总收入 (%)9.37615.41312.3368.9525.025

收益指标分析
经营活动净收益/利润总额(%)85.64692.44488.72087.75683.807
价值变动净收益/利润总额(%)12.0698.51510.43311.82118.653
营业外收支净额/利润总额(%)-7.943-3.289-2.059-6.152-12.078

偿债能力分析
流动比率 (X)2.0191.9631.8301.3761.045
速动比率 (X)1.6781.5471.4461.1100.794
资产负债率 (%)28.62928.34736.86650.67855.201
带息债务/全部投入资本 (%)13.42814.87627.32439.04042.213
股东权益/带息债务 (%)615.363545.555255.616151.090132.162
股东权益/负债合计 (%)206.489212.510146.37990.76679.589
利息保障倍数 (X)36.53765.75416.3175.3103.329

营运能力分析
应收账款周转天数 (天)97.98478.21387.082103.975114.391
存货周转天数 (天)141.725130.521124.413130.958160.520